Literature DB >> 18355307

Prevalence of disabling spasticity 1 year after first-ever stroke.

E Lundström1, A Terént, J Borg.   

Abstract

OBJECTIVE: To estimate the prevalence of disabling spasticity (DS) 1 year after first-ever stroke.
DESIGN: Cross-sectional survey 1 year after first-ever stroke.
METHODS: Patients above 18 years from one county with first-ever stroke were identified by use of the national stroke registry. A representative sample of 163 patients was created and 140 of these were followed up. Assessments of motor function and ability with the modified Ashworth Scale, the modified Rankin Scale (mRS), the Barthel Index (BI) and clinical evaluation were performed in order to identify patients with spasticity-related disability.
RESULTS: The observed prevalence of any spasticity was 17% and of DS 4%. Patients with DS scored significantly worse than those with no DS on the mRS (P = 0.009) and the BI (P = 0.005). DS was more frequent in the upper extremity, correlated positively with other indices of motor impairment and inversely with age. There was an independent effect of severe upper extremity paresis (OR 22, CI 3.9-125) and age below 65 years (OR 9.5, CI 1.5-60).
CONCLUSIONS: The prevalence of DS after first-ever stroke is low but corresponds to a large number of patients and deserves further attention with regards to prevention and treatment.

Entities:  

Mesh:

Year:  2008        PMID: 18355307     DOI: 10.1111/j.1468-1331.2008.02114.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  54 in total

1.  [Botulinum toxin in the treatment of adult spasticity. An interdisciplinary German 10-point consensus 2010].

Authors:  J Wissel; M auf dem Brinke; M Hecht; C Herrmann; M Huber; S Mehnert; I Reuter; A Schramm; A Stenner; C van der Ven; M Winterholler; A Kupsch
Journal:  Nervenarzt       Date:  2011-04       Impact factor: 1.214

Review 2.  Post-stroke remodeling processes in animal models and humans.

Authors:  Carla Cirillo; Nabila Brihmat; Evelyne Castel-Lacanal; Alice Le Friec; Marianne Barbieux-Guillot; Nicolas Raposo; Jérémie Pariente; Alain Viguier; Marion Simonetta-Moreau; Jean-François Albucher; Jean-Marc Olivot; Franck Desmoulin; Philippe Marque; François Chollet; Isabelle Loubinoux
Journal:  J Cereb Blood Flow Metab       Date:  2019-10-23       Impact factor: 6.200

3.  Comparison of surface and ultrasound localization to identify forearm flexor muscles for botulinum toxin injections.

Authors:  M Kristi Henzel; Michael C Munin; Christian Niyonkuru; Elizabeth R Skidmore; Douglas J Weber; Ross D Zafonte
Journal:  PM R       Date:  2010-07       Impact factor: 2.298

4.  Botulinum Toxin Type A Improves Function According to Goal Attainment in Adults with Poststroke Lower Limb Spasticity in Real Life Practice.

Authors:  Lourdes López de Munain; Josep Valls-Solé; Irene Garcia Pascual; Pascal Maisonobe
Journal:  Eur Neurol       Date:  2019-11-14       Impact factor: 1.710

5.  Early development of spasticity following stroke: a prospective, observational trial.

Authors:  Jörg Wissel; Ludwig D Schelosky; Jeffrey Scott; Walter Christe; Jürgen H Faiss; Jörg Mueller
Journal:  J Neurol       Date:  2010-02-06       Impact factor: 4.849

Review 6.  Upper Limb Motor Impairment After Stroke.

Authors:  Preeti Raghavan
Journal:  Phys Med Rehabil Clin N Am       Date:  2015-08-25       Impact factor: 1.784

7.  Comparing the validity of the Modified Modified Ashworth Scale (MMAS) and the Modified Tardieu Scale (MTS) in the assessment of wrist flexor spasticity in patients with stroke: protocol for a neurophysiological study.

Authors:  Hamid Abolhasani; Noureddin Nakhostin Ansari; Soofia Naghdi; Korosh Mansouri; Nastaran Ghotbi; Scott Hasson
Journal:  BMJ Open       Date:  2012-11-19       Impact factor: 2.692

8.  Therapeutic use of botulinum toxin in neurorehabilitation.

Authors:  Domenico Intiso
Journal:  J Toxicol       Date:  2011-09-14

9.  Incidence estimate and guideline-oriented treatment for post-stroke spasticity: an analysis based on German statutory health insurance data.

Authors:  Veronika Egen-Lappe; Ingrid Köster; Ingrid Schubert
Journal:  Int J Gen Med       Date:  2013-03-13

10.  Upper limb international spasticity study: rationale and protocol for a large, international, multicentre prospective cohort study investigating management and goal attainment following treatment with botulinum toxin A in real-life clinical practice.

Authors:  Lynne Turner-Stokes; Klemens Fheodoroff; Jorge Jacinto; Pascal Maisonobe; Benjamin Zakine
Journal:  BMJ Open       Date:  2013-03-18       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.